Skip to content

A prospective, randomized controlled, non-inferiority clinical trial to evaluate the efficacy and safety of plasma radiofrequency generator with polypectomy snare for cutting and clotting tissues in the digestive tract

A prospective, randomized controlled, non-inferiority clinical trial to evaluate the efficacy and safety of plasma radiofrequency generator with polypectomy snare for cutting and clotting tissues in the digestive tract

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000041576
Enrollment
Unknown
Registered
2020-12-30
Start date
2019-10-29
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

digestive tract disease

Interventions

experimental group:plasma radiofrequency generator and polypectomy snare
control group:electrosurgical system and polypectomy snare

Sponsors

Zhongshan Hospital Affiliated to Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Able to understand and willing to participate in this clinical trial, and voluntarily sign the informed consent; 2. Ages >= 18 years and <= 70 years, male or female; 3. Patients who need EMR (Endoscopic Mucosal Resection) procedure; 4. Has no more than 5 lesions of 8 - 20 mm in size; If the answer to any one question above is No, the patient shall be excluded from this clinical trial.

Exclusion criteria

Exclusion criteria: 1. Patient with coagulations disorders which is the contraindication to surgical procedures, or is still taking anticoagulant one week before surgery. 2. Patient with severe cardiopulmonary insufficiency who cannot tolerate the operation; 3. Women of childbearing age with blood pregnancy or urine pregnancy test yielding a positive result, or in lactation period; 4. Patient with cardiac pacemakers or other electronic implants; 5. The investigator believes that there are other factors that are not suitable for inclusion or influence the subject's participation of the study. If the answer to any one question above is Yes, the patient shall be excluded from this clinical trial. Note: Coagulation disorder is indicated by prolonged Prothrombin Time (PT) for more than 3 seconds (5 seconds if patient has liver disease), or prolonged activated partial thromboplastin time (APTT) for more than 10 seconds, or Platelet count (PLT) is less than 70 x 10^9/L.

Design outcomes

Primary

MeasureTime frame
En bloc resection success rates;

Secondary

MeasureTime frame
Success rate of coagulation;Device performance evaluation;Incidence of bleeding during operation;Incidence of perforation during operation;Incidence of bleeding post-toperative;Incidence of perforation post-operation;

Countries

China

Contacts

Public ContactPinghong Zhou

Zhongshan Hospital Affiliated to Fudan University

zhou.pinghong@zs-hospital.sh.cn+86 136 8197 1063

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026